8-k filing on that boss:
Item 7.01 Regulation FD Disclosure.
On April 9, 2010, Cell Therapeutics, Inc.’s (the “Company”) following a mandatory request from CONSOB pursuant to Section 114 of Legislative Decree n. 58/1998, issued an Italian press release in Italy entitled “Cell Therapeutics Provides Information Regarding Reports of Possible Takeover Bids by Novartis.” In the press release, the Company confirmed what was previously disclosed on its March 25, 2010 conference call that the Company is in discussions with Novartis Oncology with regards to development and commercialization of its pixantrone drug candidate, but has no comment on the reports of a potential takeover of the Company by Novartis. An English translation of the press release is furnished and not filed pursuant to Item 7.01 as Exhibit 99.1 hereto.